ORGANIC
LETTERS
2
002
Vol. 4, No. 14
445-2448
Oxiranyl Anion-Mediated Synthesis of
Highly Enantiomerically Enriched
Styrene Oxide Derivatives
2
Vito Capriati, Saverio Florio,* Renzo Luisi, and Antonio Salomone
C.N.R., Istituto di Chimica dei Composti OrganoMetallici-ICCOM,
Sezione di Bari, Dipartimento Farmaco-Chimico, UniVersit a` di Bari,
Via E.Orabona 4, I-70126 Bari, Italy
Received May 20, 2002
ABSTRACT
The stereospecific r-lithiation of optically active styrene oxides and the trapping reaction of the corresponding highly reactive intermediates
with electrophiles to produce optically active styrene oxide derivatives are described. This methodology has been applied to the synthesis of
an optically active oral antifungal agent of industrial interest.
5
The utility of optically active styrene oxide derivatives as
chiral building blocks for the synthesis of natural products
and biologically active compounds is well documented.
lation chemistry followed by stereospecific cyclodehydra-
6
7
tion. The successful use of the Mitsunobu reaction and of
the asymmetric reduction of substituted 2-sulfonyloxyac-
etophenone derivatives for the stereoselective synthesis of
1
8
Accordingly, efforts have been made for the development
of catalytic, stereoselective epoxidation methodologies of
styrene oxides have been also recently described.
2
To our knowledge, the oxiranyl anion-based methodology9
directed to the preparation of enantiomerically enriched
styrene oxide derivatives has not been investigated yet,
terminal olefins. The hydrolytic kinetic resolution of terminal
epoxides using chiral (salen)-Cr and (salen)-Co(III) com-
3
4
plexes and of epoxide hydrolases has also been developed.
10
Indirect routes are based mainly on asymmetric dihydroxy-
although some evidences reported by Eisch on racemic cis-
disubstituted â-phenylepoxysilanes and cis- and trans-
diphenyloxiranes and by our group on â-aryl-substituted
(1) For recent examples, see: (a) Hattori, K.; Nagano, M.; Kato, T.;
11
Nakanishi, I.; Imai, K.; Kinoshita, T.; Sakane, K. Bioorg. Med. Chem. Lett.
oxazolinyloxiranes have proved the configurational stability
1
995, 5, 2821-2824. (b) Di Fabio, R.; Pietra, C.; Thomas, R. J.; Ziviani,
L. Bioorg. Med. Chem. Lett. 1995, 5, 551-554. (c) Sher, P. M.; Mathur,
A.; Fisher, L. G.; Wu, G.; Skwish, S.; Michel, I. M.; Seiler, S. M.;
Dickinson, K. E. J. Bioorg. Med. Chem. Lett. 1997, 7, 1583-1588.
(5) For a review, see: Kolb, H. C.; Sharpless, K. B. Transition Met.
Org. Synth. 1998, 2, 219.
(6) (a) Jang, D. O.; Joo, Y. H.; Cho, D. H. Synth. Commun. 2000, 4489.
(b) For a review, see: Kolb, H. C.; Van Nieuwenhze, M. S.; Sharpless, K.
B. Chem. ReV. 1994, 94, 2483. (c) Adiyaman, M.; Khanapure, S. P.; Hwang,
S. W.; Rokack, J. Tetrahedron Lett. 1995, 7367. (d) O’Donnell, C. J.; Burke,
S. D. J. Org. Chem. 1998, 63, 8614.
(2) (a) Collman, J. P.; Wang, Z.; Straumanis, A.; Quelquejeu, M.; Rose,
E. J. Am. Chem. Soc. 1999, 121, 460. (b) Palucki, M.; Popisil, P. J.; Zhang,
W.; Jacobsen, E. N. J. Am. Chem. Soc. 1994, 116, 9333. (c) For a review,
see: Jacobsen, E. N.; Wu, M. H. In ComprehensiVe Asymmetric Catalysis;
Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer: New York,
1
6
1
999; Vol. II, Chapter 18.2. (d) Warren, J. D.; Shi, Y. J. Org. Chem. 1999,
4, 7675-7677. (e) Tian, H.; She, X.; Xu, J.; Shi, Y. Org. Lett. 2001, 3,
929.
(7) Weissman, S. A.; Rossen, K.; Reider, P. J. Org. Lett. 2001, 3, 2513.
(8) Cho, B. T.; Choi, O. K. Bull. Korean Chem. Soc. 2001, 22, 443-
444 and references therein.
(9) (a) Satoh, T. Chem. ReV. 1996, 96, 3303-3325. (b) Mori, Y. ReV.
Heteroatom Chem. 1997, 17, 183-211. (c) Hodgson, D. M.; Norsikian, S.
L. M. Org. Lett. 2001, 3, 461-463. (d) Yamauchi, Y.; Katagiri, T.;
Uneyama, K. Org. Lett. 2002, 4, 173-176.
(10) (a) Eisch, J. J.; Galle, J. E. J. Organomet. Chem. 1988, 341, 293-
313. (b) Eisch, J. J.; Galle, J. E. J. Org. Chem. 1990, 55, 4835-4840.
(11) Capriati, V.; Degennaro, L.; Favia, R.; Florio, S.; Luisi, R. Org.
Lett. 2002, 4 (9), 1551-1554.
(3) (a) Tokunaga, M.; Larrow, J. F.; Kakiuchi, F.; Jacobsen, E. N. Science
1
997, 277, 936-938. (b) Brandes, B. D.; Jacobsen, E. N. Tetrahedron:
Asymmetry 1997, 8, 3927. (c) Keith, J. M.; Larrow, J. F.; Jacobsen, E. N.
AdV. Synth. Catal. 2001, 343, 5-26. (d) Schaus, S. E.; Brandes, B. D.;
Larrow, J. F.; Tokunaga, M.; Hansen, K. B.; Gould, A. E.; Furrow, M. E.;
Jacobsen, E. N. J. Am. Chem. Soc. 2002, 124, 1307-1315.
(4) For an application, see: Pedragosa-Moreau, S.; Morriseau, C.; Zylber,
J.; Archelas, A.; Baratti, J.; Furstoss, R. J. Org. Chem. 1996, 61, 7402.
1
0.1021/ol026212d CCC: $22.00 © 2002 American Chemical Society
Published on Web 06/13/2002